Exagen
XGN
41 hedge funds and large institutions have $25.1M invested in Exagen in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
27% more capital invested
Capital invested by funds: $19.7M → $25.1M (+$5.34M)
24% more funds holding
Funds holding: 33 → 41 (+8)
2.05% less ownership
Funds ownership: 36.7% → 34.65% (-2%)
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
81% less call options, than puts
Call options by funds: $5K | Put options by funds: $26K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$3.21M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.51M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$57.8K |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$53.8K |
| 5 |
VF
Virtu Financial
New York
|
+$40.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$1.61M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.02M |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$127K |
| 4 |
Renaissance Technologies
New York
|
-$72.3K |
| 5 |
PM
Penbrook Management
New York
|
-$66.2K |
XGN Hedge Fund Activity: Q4 2024 in Review
41 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q4 2024, worth a combined $25.1M — up 27% from $19.7M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new XGN positions and 2 closed out — a net gain of 8 holders — while 8 added to existing stakes and 14 trimmed.
The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $3.21M. The largest seller was Wasatch Advisors, cutting an estimated $1.61M.
- 41 institutional investors held Exagen (XGN) as of Q4 2024, up from 33 in Q3 2024.
- Funds reported $25.1M of Exagen stock for Q4 2024, up 27% quarter-over-quarter.
- 10 funds opened new Exagen positions in Q4 2024 and 2 closed out, a net change of +8 holders.
- The largest Exagen buyer in Q4 2024 was Toronto Dominion Bank, an estimated $3.21M added.
- The largest Exagen seller in Q4 2024 was Wasatch Advisors, an estimated $1.61M sold.
Based on aggregated 13F filings for Q4 2024.